Lansoprazole plus clarithromycin: evaluation of a new dual therapy for helicobacterpylori eradication

British Journal of Clinical Practice

Volumn 50, Issue 7, 1996, Pages 360-362

  Phull, P S ^a,b   Price, A B ^a   Haluday, D ^a   Jacyna, M R ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; CLARITHROMYCIN; LANSOPRAZOLE; MACROLIDE; STOMACH SECRETION INHIBITOR; UREA;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAM NEGATIVE INFECTION; HEADACHE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; TONGUE DISEASE; VERTIGO;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PILOT PROJECTS;

EID: 0030453477     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rathbone BJ, Heatley RV. Eds. Helicobacter pylori anil Gastroduodennl Disease. 2nd edn. Oxford: Blackwell. 1992.
2. Chiba N. Rademaker JW, Rao BV. Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicatine Helicotxicter pxlori. Am J Gustwentewl 1992; 87: 1716-1727.
3. Bell GD. Powell K. Burridge SM et al. Experience with triple antiHelicobacter pylori eradication therapy - side-effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Phannacol Ther 1992; 6: 427-435.
4. Axon ATR. The role of acid inhibition in the treatment of Helicohacter pylori infection. Scant] J Gastroentervl 1994: 26 (suppl 201): 16-23.
5. Iwahi T. Satoh H. Nakao M et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicwh Agents Chemother (991: 35: 490-496.
6. Hardy DJ. Hanson CW. Hensey DM et al. Susceptibility of Campylohacter priori to macrolides and fluoroquinolones. ./ Antimicroh Chemother 19X8: 22: 631-636.
7. Graham DY. Opekun AR, Klein PD. Clarithromycin tor the eradication of Helicohacler pylori. J C/iii GastrwnU'ml 1993': 16: 292-294.
8. Peterson WL. Graham DY. Marshall B et al. Clarithromycin as monotherapy for eradication of Helicohacter p\lori: a randomized, doubleblind trial. Am J Gastroeiiterol 1993:88: 1860-1864.
9. Logan RPH. Dill S. Bauer FE et al. The European MC-urea breath test for the detection of Helictibacter pylori. Eur J Gaslroenteml Hepaiol 1991:3: 915-921.
10. Logan RPH, Gummett PA, Schaufelberger HD et al. Eradication of Helicobacterpylori with clarithromycin and omeprazole. Gut 1994; 35: 323-326.
11. Lamouliatte H, Bernard PH, Cayla R et al. Effect of lansoprazole against Helicohacter pylori in vivo. Ir J Med Sei 1992; 161 (suppl 10): 16-17.
12. Logan RPH, Gummett PA, Thomas P et al. The dose and frequency of omeprazole influence the eradication rate of dual therapy. Ada Gastro-Enterol Belgien 1993; 56 (suppl): 140.
13. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-368.